Skip to main content

Table 3 Quantitative coronary angiography analysis

From: A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

 

DES

DCB

p-value

Pre-procedure

 n

51

24

 

 LMCA RVD (mm)

3.93 ± 0.60

3.86 ± 0.79

0.67

 LMCA MLD (mm)

3.40 ± 1.13

3.47 ± 0.92

0.79

 LMCA DS (%)

14.54 ± 23.76

10.35 ± 14.76

0.60

 LAD RVD (mm)

2.72 ± 0.86

3.10 ± 0.78

0.43

 LAD MLD (mm)

0.99 ± 0.84

0.98 ± 0.97

0.95

 LAD DS (%)

66.57 ± 27.50

69.12 ± 27.95

0.71

 LCX RVD (mm)

2.80 ± 0.74

2.91 ± 0.48

0.96

 LCX MLD (mm)

1.93 ± 1.09

1.88 ± 1.23

0.94

 LCX DS (%)

33.82 ± 35.98

37.00 ± 37.69

0.83

 Target lesion RVD (mm)

2.94 ± 0.36

3.03 ± 0.77

0.48

 Target lesion MLD (mm)

0.74 ± 0.61

0.62 ± 0.47

0.41

 Target lesion DS (mm)

74.98 ± 20.09

79.75 ± 13.39

0.29

 Target lesion length (mm)

19.12 ± 8.14

18.46 ± 4.56

0.59

Post-procedure

 LMCA RVD (mm)

3.96 ± 0.58

3.88 ± 0.77

0.64

 LMCA MLD (mm)

3.75 ± 0.69

3.65 ± 0.66

0.58

 LMCA DS (%)

5.51 ± 7.89

5.63 ± 4.63

0.94

 LAD RVD (mm)

3.12 ± 0.36

3.14 ± 0.75

0.35

 LAD MLD (mm)

2.81 ± 0.51

2.79 ± 0.37

0.23

 LAD DS (%)

9.65 ± 13.40

9.65 ± 9.99

0.40

 LCX RVD (mm)

2.97 ± 0.45

2.92 ± 0.49

0.55

 LCX MLD (mm)

2.51 ± 0.63

2.59 ± 0.67

0.60

 LCX DS (%)

15.45 ± 18.54

11.99 ± 15.07

0.33

 Target lesion RVD (mm)

3.12 ± 0.39

3.08 ± 0.74

0.11

 Target lesion MLD (mm)

2.85 ± 0.55

2.71 ± 0.29

0.03

 Target lesion DS (%)

8.68 ± 12.70

10.00 ± 9.91

0.12

 Acute gain (mm)

2.12 ± 0.80

2.09 ± 0.50

0.89

Follow-up

 n

25

13

 

 Median follow-up period (day)

294

560

0.66

 LMCA RVD (mm)

3.91 ± 0.55

3.70 ± 0.56

0.27

 LMCA MLD (mm)

3.42 ± 0.94

3.25 ± 0.75

0.59

 LMCA DS (%)

12.76 ± 19.60

12.51 ± 11.68

0.57

 LAD RVD (mm)

3.07 ± 0.67

3.04 ± 0.44

0.87

 LAD MLD (mm)

2.33 ± 1.01

2.01 ± 1.09

0.37

 LAD DS (%)

20.01 ± 48.10

33.07 ± 33.83

0.85

 LCX RVD (mm)

2.76 ± 0.40

2.71 ± 0.74

0.69

 LCX MLD (mm)

1.79 ± 1.00

1.61 ± 0.91

0.37

 LCX DS (%)

35.85 ± 35.67

40.70 ± 30.60

0.59

 Target lesion RVD (mm)

3.00 ± 0.71

2.91 ± 0.35

0.53

 Target lesion MLD (mm)

2.34 ± 1.04

1.68 ± 0.96

0.04

 Target lesion DS (%)

19.61 ± 48.63

40.37 ± 34.61

0.31

 Late lumen loss (mm)

0.60 ± 0.85

1.06 ± 1.10

0.23

 Binary restenosis, n (%)

5 (20)

6 (46.2)

0.14

  1. Data were presented as n (%) or mean ± SD. DCB drug-coated balloon; DES drug-eluting stent; DS diameter stenosis; LAD left anterior descending artery; LCX left circumflex artery; LMCA left main coronary artery; MLD minimal lumen diameter; RVD reference vessel diameter
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us